fidaxomicin

Details

Files

Generic Name:

fidaxomicin

Project Status:

Active

Therapeutic Area:

Clostridium difficile infection

Manufacturer:

N/A

Call for patient/clinician input open:

November 21, 2024

Brand Name:

N/A

Project Line:

Reimbursement Review

Project Number:

SX0754-000

Call for patient/clinician input closed:

January 17, 2025

NOC Status at Filing:

N/A

Biosimilar:

Submission Type:

Non-sponsored Submission

Fee Schedule:

N/A

Indications:

For the treatment of adults with Clostridium difficile infection.

Key Milestones²
Milestones title	Date
Submission received	November 22, 2024
Expert committee meeting (initial)	May 15, 2025

Last Updated : January 7, 2025